Long-term survival after gamma knife radiosurgery for primary and metastatic brain tumors.
In this paper, we studied factors related to long-term survival after gamma knife radiosurgery (GKS) for primary and metastatic brain tumors. We examined all cases of brain metastases and malignant glioma treated with GKS between September 1994 and December 1998. All patients with survival exceeding 2 years were studied retrospectively using prospectively acquired data. A total of 22 patients, with an average age of 56, were identified, which accounts for 11% of the total patients treated during this time interval. Seventeen of 22 are still alive with a mean follow-up of 48 months. Sixteen patients had metastatic tumors, whereas 6 had a malignant glioma. Thirteen of 15 patients with metastases had a controlled primary site, and the other 2 patients did not have a primary site identified. These 2 patients were among the 3 that died during the follow-up period. Fourteen patients developed symptomatic radiation necrosis by MRI criteria with 4 confirmed by biopsy. Quality-of-life factors were assessed in 20 of 22 patients using a modified Spitzer scale, which showed a high level of functioning in all of the long-term survivors (mean score 8.65 of 10), and only 1 patient had a Karnofsky Performance Score of less than 70. We conclude that radiosurgery provides a noninvasive and effective way of controlling brain tumors, while preserving quality of life.
Jagannathan
Jay
J
Department of Neurological Surgery, University of Maryland Medical Center, Baltimore, MD 21201-1595, USA.
Petit
Joshua H
JH
Balsara
Karl
K
Hudes
Richard
R
Chin
Lawrence S
LS
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001932:Brain Neoplasms / Q000473:pathology / Q000556:secondary / Q000601:surgery*; D005260:Female; D005910:Glioma / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D016634:Radiosurgery; D015996:Survival Rate; D017741:Survivors